Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TCAIM Tunes OGDH to Regulate Mitochondrial Metabolism
2026-09-23
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that binds native OGDH and promotes its reduction through HSPA9 and LONP1. The resulting decrease in OGDH complex activity changes carbohydrate catabolism, revealing a protein-turnover mechanism for regulating mitochondrial metabolism.
-
Red Blood Cell Membrane Bending Rigidity
2026-09-23
The reference study isolates the red blood cell cytoplasmic membrane from the spectrin network and ATP-dependent effects to determine its intrinsic bending rigidity. By integrating X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations, the authors estimate a relatively low bending modulus of approximately 4–6 kBT, clarifying why earlier whole-cell measurements varied so widely.
-
Avian Hair-Cell Ablation and Regeneration Protocol
2026-09-22
The reference paper presents an integrated workflow for inducing auditory hair-cell loss in young chickens and simultaneously assessing regenerative responses through multiplexed mRNA detection, immunohistochemistry, and EdU labeling. Its main contribution is methodological: it connects controlled inner-ear injury with spatial, protein-level, and cell-cycle readouts that can improve reproducibility in avian regeneration studies.
-
Temafloxacin Pharmacokinetics and Translational Limits
2026-09-22
The 1991 review of temafloxacin integrates oral and intravenous pharmacokinetics, distribution, elimination, renal function, and dosing implications into a clinically useful framework. Its high bioavailability, approximately 8-hour terminal half-life, and substantial unchanged urinary recovery support flexible dosing, while the healthy-volunteer design also defines important limits for extrapolation to other antimicrobial compounds.
-
Carbapenemase Gene Transmission in CREC, 2022–2024
2026-09-21
Chen et al. mapped carbapenemase-encoding genes, their genomic locations, transferability, and strain relatedness in carbapenem-resistant Enterobacter cloacae from eight Guangdong teaching hospitals. The findings emphasize plasmid-associated blaNDM-1, efficient horizontal dissemination, and the need to combine susceptibility testing with molecular surveillance and infection-control analysis.
-
Apigenin Assay Design: Reliable Cell Data
2026-09-21
This scenario-based guide explains how Apigenin (SKU N1828) can support reproducible cell viability, proliferation, cytotoxicity, and mechanistic assays. It covers dose selection, DMSO handling, assay interpretation, cross-domain evidence, and practical vendor evaluation.
-
Spermine: Mechanism, Benchmarks, and Research Use
2026-09-20
Spermine is an endogenous polyamine that supports eukaryotic cell growth and protein synthesis while modulating inward rectifier potassium channels. The C4910 product is documented for research workflows involving IRK1 channel regulation, cellular metabolism research, and controlled solution preparation.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Assay Guide
2026-09-19
Learn how ARCA Cy3 EGFP mRNA (5-moUTP) separates cellular uptake, endosomal escape, and EGFP reporter gene expression. This assay-focused guide translates recent lipid nanoparticle findings into practical mRNA delivery decisions.
-
N2703 in Adipose-Neural Arrhythmia Research
2026-09-18
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) is a high-purity small-molecule research reagent with documented solvent solubility and refrigerated storage guidance. Its use in adipose-neural cardiac arrhythmia models is hypothesis-driven because the cited preprint establishes the disease pathway but does not report N2703 testing.
-
SpCas9 mRNA: From Chemistry to Translation
2026-09-18
A translational guide to SpCas9 mRNA chemistry, delivery, genome editing performance, and the strategic lessons of lipid nanoparticle-enabled pulmonary editing.
-
How GCG Disrupts SARS-CoV-2 N Condensates
2026-09-17
The reference study identifies RNA-driven liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein as a virus-relevant process and shows that (-)-gallocatechin gallate disrupts this condensation. Its combination of proteome-wide prediction, variant analysis, biochemical assays, and infection models provides a framework for studying antiviral mechanisms that target biomolecular condensates.
-
Actinomycin D in Ybx1 RNA Stability Studies
2026-09-17
Actinomycin D is more than a cytotoxic transcriptional inhibitor: it is a temporal tool for testing RNA stability. This article explains how ActD can sharpen interpretation of the Ybx1–mRNA stability axis in cortical neurogenesis while controlling for transcriptional stress and apoptosis.
-
AZD8055 Workflow for mTOR Pathway Studies
2026-09-16
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and metabolic responses. This guide focuses on practical cell and animal workflow design while defining limits for aqueous formulations, clinical efficacy interpretation, and unsupported dose extrapolation.
-
TJP3, Anoikis, and Breast Cancer Drug Resistance
2026-09-16
This study integrates anoikis-related gene profiling, machine-learning prognostic modeling, and experimental validation to identify breast cancer subgroups with distinct immune and chemotherapy-response features. TJP3 emerged as a candidate regulator associated with paclitaxel tolerance, migration, epithelial–mesenchymal transition markers, and potential immune escape, although the evidence remains largely associative and requires prospective validation.
-
Ferrostatins, Lipid Damage, and Ferroptosis
2026-09-15
Skouta and colleagues showed that ferrostatin-1 protects cells by suppressing oxidative lipid damage rather than by broadly eliminating all reactive oxygen species. Their cross-model experiments connected lipid peroxidation with ferroptotic cell death and used mechanistic insight to guide the design of improved ferrostatin analogues.